1.
Bashir A, Nadeem M, Nasir M, Bangash MH, Khattak R, Khan A. Response Assessment to Neoadjuvant Treatment with Dual HER2 Blocker in HER2 positive Early and Locally Advanced Breast Cancer. Pak Armed Forces Med J [Internet]. 2026 May 28 [cited 2026 Jun. 7];76(SUPPL-5):S729-S732. Available from: https://www.pafmj.org/PAFMJ/article/view/10388